- Home
- NPCE vs RAPP Comparison
NPCE vs RAPP Comparison
Compare NPCE & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- RAPP
- Stock Information
- Founded
- NPCE 1997
- RAPP 2022
- Country
- NPCE United States
- RAPP United States
- Employees
- NPCE N/A
- RAPP N/A
- Industry
- NPCE Medical Specialities
- RAPP
- Sector
- NPCE Health Care
- RAPP
- Exchange
- NPCE Nasdaq
- RAPP Nasdaq
- Market Cap
- NPCE 424.1M
- RAPP 450.0M
- IPO Year
- NPCE 2021
- RAPP 2024
- Fundamental
- Price
- NPCE $10.39
- RAPP $12.04
- Analyst Decision
- NPCE Buy
- RAPP Strong Buy
- Analyst Count
- NPCE 7
- RAPP 2
- Target Price
- NPCE $15.14
- RAPP $35.00
- AVG Volume (30 Days)
- NPCE 412.6K
- RAPP 164.1K
- Earning Date
- NPCE 08-12-2025
- RAPP 08-07-2025
- Dividend Yield
- NPCE N/A
- RAPP N/A
- EPS Growth
- NPCE N/A
- RAPP N/A
- EPS
- NPCE N/A
- RAPP N/A
- Revenue
- NPCE $84,306,000.00
- RAPP N/A
- Revenue This Year
- NPCE $21.00
- RAPP N/A
- Revenue Next Year
- NPCE $11.81
- RAPP N/A
- P/E Ratio
- NPCE N/A
- RAPP N/A
- Revenue Growth
- NPCE 22.05
- RAPP N/A
- 52 Week Low
- NPCE $5.45
- RAPP $6.43
- 52 Week High
- NPCE $18.98
- RAPP $29.74
- Technical
- Relative Strength Index (RSI)
- NPCE 36.54
- RAPP N/A
- Support Level
- NPCE $10.10
- RAPP N/A
- Resistance Level
- NPCE $11.53
- RAPP N/A
- Average True Range (ATR)
- NPCE 0.66
- RAPP 0.00
- MACD
- NPCE -0.00
- RAPP 0.00
- Stochastic Oscillator
- NPCE 28.15
- RAPP 0.00
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.